Correlation between mRNAseq expression and clinical features
Prostate Adenocarcinoma (Primary solid tumor)
21 April 2013  |  analyses__2013_04_21
Maintainer Information
Citation Information
Maintained by Juok Cho (Broad Institute)
Cite as Broad Institute TCGA Genome Data Analysis Center (2013): Prostate Adenocarcinoma (Primary solid tumor cohort) - 21 April 2013: Correlation between mRNAseq expression and clinical features. Broad Institute of MIT and Harvard. doi:10.7908/C1WM1BCS
Overview
Introduction

This pipeline uses various statistical tests to identify mRNAs whose expression levels correlated to selected clinical features.

Summary

Testing the association between 18257 genes and 4 clinical features across 153 samples, statistically thresholded by Q value < 0.05, 3 clinical features related to at least one genes.

  • 1 gene correlated to 'AGE'.

    • ADAP2|55803

  • 30 genes correlated to 'RADIATIONS.RADIATION.REGIMENINDICATION'.

    • C14ORF126|112487 ,  CEBPZ|10153 ,  ABHD11|83451 ,  SFRS2|6427 ,  MCOLN2|255231 ,  ...

  • 1 gene correlated to 'COMPLETENESS.OF.RESECTION'.

    • GLP2R|9340

  • No genes correlated to 'NUMBER.OF.LYMPH.NODES'

Results
Overview of the results

Complete statistical result table is provided in Supplement Table 1

Table 1.  Get Full Table This table shows the clinical features, statistical methods used, and the number of genes that are significantly associated with each clinical feature at Q value < 0.05.

Clinical feature Statistical test Significant genes Associated with                 Associated with
AGE Spearman correlation test N=1 older N=1 younger N=0
RADIATIONS RADIATION REGIMENINDICATION t test N=30 yes N=8 no N=22
COMPLETENESS OF RESECTION ANOVA test N=1        
NUMBER OF LYMPH NODES Spearman correlation test   N=0        
Clinical variable #1: 'AGE'

One gene related to 'AGE'.

Table S1.  Basic characteristics of clinical feature: 'AGE'

AGE Mean (SD) 60.49 (6.9)
  Significant markers N = 1
  pos. correlated 1
  neg. correlated 0
List of one gene significantly correlated to 'AGE' by Spearman correlation test

Table S2.  Get Full Table List of one gene significantly correlated to 'AGE' by Spearman correlation test

SpearmanCorr corrP Q
ADAP2|55803 0.388 7.87e-07 0.0144

Figure S1.  Get High-res Image As an example, this figure shows the association of ADAP2|55803 to 'AGE'. P value = 7.87e-07 with Spearman correlation analysis. The straight line presents the best linear regression.

Clinical variable #2: 'RADIATIONS.RADIATION.REGIMENINDICATION'

30 genes related to 'RADIATIONS.RADIATION.REGIMENINDICATION'.

Table S3.  Basic characteristics of clinical feature: 'RADIATIONS.RADIATION.REGIMENINDICATION'

RADIATIONS.RADIATION.REGIMENINDICATION Labels N
  NO 5
  YES 148
     
  Significant markers N = 30
  Higher in YES 8
  Higher in NO 22
List of top 10 genes differentially expressed by 'RADIATIONS.RADIATION.REGIMENINDICATION'

Table S4.  Get Full Table List of top 10 genes differentially expressed by 'RADIATIONS.RADIATION.REGIMENINDICATION'

T(pos if higher in 'YES') ttestP Q AUC
C14ORF126|112487 -10.72 3.125e-17 5.47e-13 0.8527
CEBPZ|10153 -10.55 2.889e-16 5.05e-12 0.8554
ABHD11|83451 12.03 4.211e-12 7.37e-08 0.9108
SFRS2|6427 -10.08 3.636e-11 6.36e-07 0.8392
MCOLN2|255231 -7.14 1.947e-10 3.41e-06 0.7054
CDC40|51362 -9.28 3.636e-10 6.36e-06 0.8514
TMEM161B|153396 -8.76 2.362e-09 4.13e-05 0.8851
SFRS13A|10772 -9.78 3.218e-09 5.63e-05 0.873
ABCD1|215 8.33 3.263e-09 5.71e-05 0.8122
PPIG|9360 -7.15 4.42e-09 7.73e-05 0.7095

Figure S2.  Get High-res Image As an example, this figure shows the association of C14ORF126|112487 to 'RADIATIONS.RADIATION.REGIMENINDICATION'. P value = 3.13e-17 with T-test analysis.

Clinical variable #3: 'COMPLETENESS.OF.RESECTION'

One gene related to 'COMPLETENESS.OF.RESECTION'.

Table S5.  Basic characteristics of clinical feature: 'COMPLETENESS.OF.RESECTION'

COMPLETENESS.OF.RESECTION Labels N
  R0 117
  R1 29
  RX 2
     
  Significant markers N = 1
List of one gene differentially expressed by 'COMPLETENESS.OF.RESECTION'

Table S6.  Get Full Table List of one gene differentially expressed by 'COMPLETENESS.OF.RESECTION'

ANOVA_P Q
GLP2R|9340 9.218e-10 1.68e-05

Figure S3.  Get High-res Image As an example, this figure shows the association of GLP2R|9340 to 'COMPLETENESS.OF.RESECTION'. P value = 9.22e-10 with ANOVA analysis.

Clinical variable #4: 'NUMBER.OF.LYMPH.NODES'

No gene related to 'NUMBER.OF.LYMPH.NODES'.

Table S7.  Basic characteristics of clinical feature: 'NUMBER.OF.LYMPH.NODES'

NUMBER.OF.LYMPH.NODES Mean (SD) 0.21 (0.74)
  Significant markers N = 0
Methods & Data
Input
  • Expresson data file = PRAD-TP.uncv2.mRNAseq_RSEM_normalized_log2.txt

  • Clinical data file = PRAD-TP.clin.merged.picked.txt

  • Number of patients = 153

  • Number of genes = 18257

  • Number of clinical features = 4

Correlation analysis

For continuous numerical clinical features, Spearman's rank correlation coefficients (Spearman 1904) and two-tailed P values were estimated using 'cor.test' function in R

Student's t-test analysis

For two-class clinical features, two-tailed Student's t test with unequal variance (Lehmann and Romano 2005) was applied to compare the log2-expression levels between the two clinical classes using 't.test' function in R

ANOVA analysis

For multi-class clinical features (ordinal or nominal), one-way analysis of variance (Howell 2002) was applied to compare the log2-expression levels between different clinical classes using 'anova' function in R

Q value calculation

For multiple hypothesis correction, Q value is the False Discovery Rate (FDR) analogue of the P value (Benjamini and Hochberg 1995), defined as the minimum FDR at which the test may be called significant. We used the 'Benjamini and Hochberg' method of 'p.adjust' function in R to convert P values into Q values.

Download Results

This is an experimental feature. The full results of the analysis summarized in this report can be downloaded from the TCGA Data Coordination Center.

References
[1] Spearman, C, The proof and measurement of association between two things, Amer. J. Psychol 15:72-101 (1904)
[2] Lehmann and Romano, Testing Statistical Hypotheses (3E ed.), New York: Springer. ISBN 0387988645 (2005)
[3] Howell, D, Statistical Methods for Psychology. (5th ed.), Duxbury Press:324-5 (2002)
[4] Benjamini and Hochberg, Controlling the false discovery rate: a practical and powerful approach to multiple testing, Journal of the Royal Statistical Society Series B 59:289-300 (1995)